Chronic Obstructive Pulmonary Diseases and Proprioceptive Neuromuscular Facilitation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

31 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-20

Study Completion Date

2022-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To investigate the effects of resistant proprioceptive neuromuscular facilitation exercises on physical fitness, respiratory muscle strength, walking distance and quality of life in chronic obstructive pulmonary patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Muscle Oxygenation in Chronic Obstructive Pulmonary Disease

NCT05808621

Muscle Oxygenation Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease Exacerbation

COMPLETED

The Effect of Clinical Parameters on Muscle Oxygenation in Patients With COPD

NCT06041126

Chronic Obstructive Pulmonary Disease Muscle Oxygenation Disease Severity +1 more

COMPLETED

Respiratory Muscle Strength in Patients With Idiopathic Pulmonary Fibrosis

NCT03588260

Idiopathic Pulmonary Fibrosis

COMPLETED

Comparison of Respiratory Muscle Activations During Dyspnea Reduction Positions in Individuals

NCT04983472

Chronic Obstructive Pulmonary Disease

UNKNOWN

Investigation of the Effects of Different Exercise Approaches on Clinical Parameters in Chronic Obstructive Pulmonary Disease Patients

NCT06680960

COPD (Chronic Obstructive Pulmonary Disease)

ACTIVE_NOT_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study was carried out between January 2017 and January 2019, with patients followed up with the diagnosis of COPD in Çanakkale Mehmet Akif Ersoy State Hospital and Çanakkale Onsekiz Mart University Medical Faculty Hospital, Department of Chest Diseases. It was approved by Istanbul Medipol University Non-Interventional Clinical Research Ethics Committee (Date: 30.12.2016, Decision No. 573) and was done in accordance with the Declaration of Helsinki. All participants were informed about the purpose of the study, the total duration of treatment and the applications to be made, and a consent form was signed. The study was conducted as a prospective and randomized controlled study, and inclusion and exclusion criteria were determined.

Thirty-five patients diagnosed with COPD were referred to the study, four patients were excluded because they did not meet the inclusion criteria, and the study was conducted with a total of 31 participants.

The 31 patients included in the study were randomized after their initial evaluation and divided into two groups as experimental and control groups. Patients meeting the inclusion criteria were divided into 2 groups. Randomized by ordering by date of application.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Obstructive Pulmonary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Maximal Inspiratory Pressure

MIP Maximal Inspiratory Pressure

Group Type EXPERIMENTAL

MIP/MEP

Intervention Type DIAGNOSTIC_TEST

MIP/MEP

Maximal Expiratory Pressure

MEP Maximal Expiratory Pressure

Group Type EXPERIMENTAL

MIP/MEP

Intervention Type DIAGNOSTIC_TEST

MIP/MEP

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MIP/MEP

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* To be diagnosed with stage 1, stage 2 and stage 3 COPD according to GOLD (Global Initiative for Obstructive Lung Diseases) criteria
* Having FEV1/FVC \<70% according to pulmonary function test
* Being clinically stable
* Being over 18 years old
* Volunteer to participate in the program

Exclusion Criteria

* Having a COPD exacerbation in the last 8 weeks
* To have participated in a regular exercise training program in the last 1 year
* Having a musculoskeletal disease and neuromuscular disease that may prevent exercise
* Inability to cooperate for pulmonary function test and respiratory muscle strength measurement
* Being on long-term oxygen therapy

Minimum Eligible Age

38 Years

Maximum Eligible Age

67 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes